Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

NVCT

NVCT News

Newswire

07:42

Nuvectis Pharma's Market Cap Surges US$18m: Retail Investors and Insiders Benefit

07:26

Nuvectis Pharma Director Juan Sanchez Boosts Stake by 20% with $75,000 Stock Purchase

08:06

Nuvectis Pharma Directors Make Significant Share Purchases at $5.72-$5.84/Share

08:20

Nuvectis Pharma initiates NXP900 Phase 1b program, reports successful Phase 1a results.

08:17

Nuvectis Pharma initiates NXP900 Phase 1b, targets advanced cancers.

View More

About NVCT

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More